Calando Pharmaceuticals
Pasadena, California, United States
About Calando Pharmaceuticals
Calando Pharmaceuticals is a biopharmaceutical company focused on creating targeted therapeutics using its patented and proprietary cyclodextrin-based polymer technologies for the development of nanoparticle drug formulations. Calando’s initial emphasis has been to bring targeted siRNA and small molecule therapeutics to the clinic for oncology applications; however, the technologies are not limited to these classes of molecules and are applicable to a very broad range of therapeutic entities and diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $11.0M
- Last round: Series Unknown (Jan 2011)
- Website: insertt.com
- Phone: +1 626-304-3400
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/calando-pharmaceuticals-2554950 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.